Vimarsana
Biggest News Aggregation in the World

Endocr Pract News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Endocr Pract. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Endocr Pract Today - Breaking & Trending Today

Personalized approach emphasized in AACE consensus statement for treating type 2 diabetes - Vimarsana News

Personalized approach emphasized in AACE consensus statement for treating type 2 diabetes

SEATTLE — Providers treating people with type 2 diabetes should take a complication-centric approach for determining first-line pharmacotherapy, according to a consensus statement. An update to AACE’s Comprehensive Type 2 Diabetes Management Algorithm was published in Endocrine Practice and discussed during a plenary talk at the AACE Annual Scientific and Clinical Conference. The

Source: healio.com
Don't Fall for the Myths About Soy - Vimarsana News

Don't Fall for the Myths About Soy

Contrary to the negative soy information floating about in today’s technological world, the scientific consensus shows soy is ...

Frontiers | COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020 - Vimarsana News

Frontiers | COVID-19 Pandemic and Pediatric Type 1 Diabetes: No Significant Change in Glycemic Control During The Pandemic Lockdown of 2020

Importance: There is no consensus on the impact of the 2020 COVID-19 pandemic lockdown on glycemic control in children and adolescents with type 1 diabetes (T1D) in the US. Aim: To determine the impact of the pandemic lockdown of March 15th through July 6th, 2020 on glycemic control after controlling for confounders. Subjects and Methods: An observational study of 110 subjects of mean age 14.8 ± 4.9 years(y), [male 15.4 ± 4.0y, (n=57); female 14.1 ± 3.8y, (n=53), p=0.07] with T1D of 6.31 ± 4.3y (95% CI 1.0-19.7y). Data were collected at 1-4 months before the lockdown and 1-...